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Abstract: With an increasingly elderly population, there is a proportionate increase in bone injuries
requiring hospitalization. Clinicians are increasingly adopting tissue-engineering methods for
treatment due to limitations in the use of autogenous and autologous grafts. The aim of this study was
to synthesize a novel, bioactive, porous, mechanically stable bone graft substitute/scaffold. Strontium-
and zinc-containing bioactive glasses were synthesized and used with varying amounts of alginate to
form scaffolds. Differential scanning calorimetric analysis (DSC), FTIR, XRD, and NMR techniques
were used for the characterization of scaffolds. SEM confirmed the adequate porous structure of the
scaffolds required for osteoconductivity. The incorporation of the bioactive glass with alginate has
improved the compressive strength of the scaffolds. The bioactivity of the scaffolds was demonstrated
by an increase in the pH of the medium after the immersion of the scaffolds in a Tris/HCl buffer and by
the formation of orthophosphate precipitate on scaffolds. The scaffolds were able to release calcium,
strontium and zinc ions in the Tris/HCl buffer, which would have a positive impact on osteogenesis if
tested in vivo.
Keywords: bone scaffolds; alginates; bioactive glass; strontium; zinc; composite
1. Introduction
Bone is a complex biomineralized system with an intricate hierarchical structure. It is a dynamic
structure with a unique capability to renew itself through remodelling. Microdamage occurs in our
bones because of everyday cyclical activity. It gets repaired in healthy bone, but it may result in a
fragility fracture if the repair mechanism is deficient, as in osteoporotic patients. Large skeletal defects
resulting from trauma, malignancies, and various infections are also beyond the capacity of normal
bone to repair and often require surgical intervention to restore function. The average yearly number
of bone graft surgeries performed worldwide is more than two million, costing $2.5 billion [1,2].
Fractures impose a huge burden on healthcare systems. The combined health and social care costs of
hip fractures alone in the UK came to an estimated £1 billion in 2017 [3]. The number of total joint
revisions requiring structural bone support and the number of spinal fusions requiring extensive bone
graft material is increasing due to an increase in the elderly population. Clinicians are increasingly
adopting tissue-engineering methods for treatment to avoid the risk of infection, disease transmission,
and histocompatibility differences associated with the use of autografts and allografts [4].
Thus, there is a great need to develop synthetic bone graft substitutes (scaffolds) to meet the
epidemiologically driven demand. An ideal bone scaffold should promote early mineralization and
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support new bone formation while at the same time allowing for replacement by new bone. In order to
achieve these goals, the biocompatibility and biodegradability of material is imperative. A scaffold
has to have a high interconnected porosity of appropriate size to direct cells to grow into the desired
physical form and to support the vascularization of the ingrown tissue [5]. Additionally, it should
have a large surface area that promotes cell adhesion, growth, migration, and differentiation. The
mechanical properties of the scaffold must be sufficient so that it does not collapse during the patient’s
normal activities. Other highly desirable features concerning scaffold processing are its fabrication and
scalability for cost-effective industrial production [6].
In this study, alginate and strontium- and zinc-containing bioactive glass was used to create a
composite bone scaffold. Alginates have great potential in regenerative medicine because of their
biocompatibility, biodegradability, mechanical properties, and relatively low cost [7,8]. Alginate is
a polysaccharide obtained from certain species of brown algae, and it is composed of 1,4-linked
β-D-mannuronic acid (M) and α-L-guluronic acid (G) residues. The cation and the carboxyl functional
groups of G units located on the polymer chain of alginate promote the formation of the hydrogel by the
chemical cross-linking of certain divalent cations, such as Ca2+ or Sr2+ through ionic interaction [7,8].
Alginates have been shown to be able to support the nucleation of hydroxyapatite crystals on
their surface when submerged in body fluids and simulated body fluids (SBF) [8]. An SBF solution
approximates the ionic constituents, pH, and temperature of blood plasma and has been used widely
for in vitro assessment of the bioactivity of various scaffolds.
Bioactive glasses have generated interest in the field of bone tissue engineering due to their
similarity to the natural inorganic constituent of bone. Hench and his colleagues [9,10] were the pioneers
in demonstrating the suitability of bioactive glasses as bioactive, biocompatible and osteoconductive
materials for bone tissue engineering. The addition of bioactive glass with alginates increases the latter’s
mechanical properties [11,12]. Bioactive glasses are known to influence osteoblastic cell differentiation
with an increase in the level of differentiation markers like alkaline phosphatase (ALP), osteocalcin,
and osteopontin and to enhance osteogenesis through the direct control over genes that regulate cell
cycle induction and progression towards a mature osteoblast phenotype [13–15].
In this study, we used melt-derived strontium- and zinc-containing bioactive glass in varying
ratios of alginate to synthesize bone scaffolds with the use of a simple, reproducible freeze-drying
technique [12]. Zinc and strontium are added to enhance the therapeutic behaviour of the glasses [16–18].
Zinc is not just an effective antimicrobial agent—it also stimulates osteoblast differentiation, proliferation,
and mineralization through the gene expression of various proteins including type I collagen, alkaline
phosphatase, and osteocalcin [17]. The composition of the glass used in this study had a higher
amount of strontium as compared to ICIE16M used in our earlier study [12], as it is known that
substituting strontium for calcium on a molar base enhances glass degradation and apatite formation
while providing a release of strontium ions [19]. Strontium, due to its anabolic and anti-resorptive
effects on bone, is already in use as strontium ranelate in the treatment of osteoporosis [18]. The local
delivery of strontium ranelate in bone scaffolds avoids side-effects due to systemic intake [20]. We
also added fluoride in one of the bioactive glass compositions, as it has been reported that fluoride
treatment increases bone mineral density in the spine and hip areas [21].
The rationale of this study was to synthesize and characterize a biocompatible, bioactive composite
material with sufficient porosity for use as a bone scaffold.
2. Materials and Methods
2.1. Glass Synthesis and Characterization
Two compositions of melt-derived glass were synthesized by mixing different proportions of
analytical grade SiO2, P2O5, Ca2CO3, SrCO3, Na2CO3, K2CO3, ZnO, CaF2, and SrF2 (Sigma-Aldrich,
Gillingham, UK) powders, as given in Table 1.
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Table 1. The composition of the bioactive glass (mol.%).
SiO2 P2O5 CaO CaF2 SrO SrF2 Na2O K2O ZnO Melting Temperature (◦C)
A0 36.4 6.0 26.5 2.2 26.5 2.2 0 0 0 1500
A1 44.0 5.0 15.0 0 15.0 0 10.0 10.0 1.0 1420
They were melted in a platinum-rhodium (Pt10Rh) crucible for 1 h in an electric furnace (EHF 17/3,
Lenton, Hope Valley, UK). To prevent crystallization on cooling, the glasses were rapidly quenched
into water. The coarse frit form of the glass was collected and dried overnight. The glass frits were
milled to powder form by using a vibratory gyro-mill (Gyro mill, Glen Creston, London, UK). Later, the
glass powder was sieved by using a 38 µm mesh analytical sieve (Endocotts Ltd., London, UK) [12,22].
The particle size of the bioactive glass powder was determined by using the “Master particle size
analyser” (Mastersizer E), and particle size distributions are presented as D-values (D10, D50, and
D90). A D-value is a diameter that, when all particles in a sample are arranged in order of ascending
mass, divides the sample’s mass into specified percentages. The percentage mass below the diameter
of interest is the number expressed after the “D”.
Glass powder was further characterized with the use of X-ray diffraction (XRD; X’Pert PRO,
PANalytical, Cambridge, UK) to confirm the amorphous structure of the glass. The differential scanning
calorimetric analysis (DSC, Stanton Redcroft DSC 1500 Rheometric Scientific, Epson, UK) of glass was
used to determine the transitional temperature (Tg). Fourier transform infrared spectroscopy (FTIR
spectrum GX v5.3.1)—using the software NICOLET IS10 FT-IR SPEC, Thermofisher, Waltham, MA,
USA—was used to determine the structure and chemical bonds in the glass.
2.1.1. Bone Scaffold Synthesis and Characterization
Sodium alginate (Fisher Scientific, Leicestershire, UK) and bioactive glass A1 were selected for the
fabrication of the bone scaffold. Three types of bone scaffolds were prepared with the use of different
ratios of alginate and bioactive glass (Table 2).
Table 2. Showing the weight ratio of alginate and bioactive glass (BG) A1 in three types of bone scaffolds.
Bone Scaffold Alginate: BG Mass of Alginate (g) Mass of BG (g)
Type 1 (T1) 1:0 3 0
Type 2 (T2) 1:1 3 3
Type 3 (T3) 2:1 6 3
For the preparation of the bone scaffold, the temperature of the heat pad was set to 50 ◦C. A 500 mL
glass beaker was placed with 100 mL of deionized water; 0.2 g of sodium lauryl sulfate (Sigma Aldrich
Ltd., Gillingham, UK) was added in 100 mL of distilled water in a separate beaker and mixed well. The
desired amount of alginate and bioactive glass was weighed in separate weighing boats. A thermometer
was used to measure the temperature of the deionized water. When the temperature reached 50 ◦C,
the first mixture of sodium lauryl sulfate was added, and then the alginate and bioactive glass (A1)
was added one by one. The timer was set for 20 min, which was required for the stirring of the mixer.
After 20 min, the prepared samples were poured into screw-capped bottles with a syringe. Then,
the samples were quenched with liquid nitrogen for five minutes, keeping the cap open. After 5 min,
the cap was screwed and the samples were transferred in the commercial freezer at a temperature of
−20 ◦C for 48 h. The samples were divided into two groups; one group was cross-linked with 1%
of w/v of calcium chloride (Sigma-Aldrich Ltd., UK), and the other was cross-linked with 1% w/v of
strontium chloride (Sigma-Aldrich Ltd., UK) solution for 3 h and thereafter refrozen in a commercial
freezer at −20 ◦C for 48 h. The previous cycle of the freeze-drying was repeated over the cross-linked
samples to form a final composite bone scaffold [12,23].
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The bioactivity of the scaffolds was determined by the formation of an apatite-like phase in the
Tris/HCl buffer solution. The Tris/HCl buffer solution was prepared by first dissolving 15,090 g of Tris
(hydroxymethyl) aminomethane (Sigma-Aldrich Ltd., UK) in 1500 mL of de-ionized water, and then
44.2 mL of 1 M hydrochloric acid (Sigma-Aldrich Ltd., UK) was added to this solution. The solution
was kept in a 37 ◦C incubator overnight. The pH value was adjusted to 7.3 by using 1 M hydrochloric
acid before diluting the solution up to a total volume of 2 L with de-ionized water. The solution was
stored in a 37 ◦C incubator (KS 4000i control, IKA) before use [24]. For the bioactivity test, the scaffold
samples were made into powder by grinding them with a mortar and pestle. The sample was dipped
into the Tris/HCl buffer solution in a labelled centrifuge tube and kept in the incubator with an orbital
shaker at 37 ◦C. The samples were left in the incubator for 15 h, 1, 3, and 7 days. Fixing the time
ensured the recording of release patterns at different time points. After the desired amount of time, the
samples were taken out and left alone for a few minutes to let the temperature settle down. The pH
of the sample was measured with the help of the pH meter (Oaktonertech instrument, Vernon Hills,
IL, USA).
After determining the pH, samples were filtered through filter paper in a centrifuge tube. The
precipitates obtained after the immersion was dried in the oven at 37 ◦C for 48 h and analysed by X-ray
diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and solid-state nuclear magnetic
resonance (NMR).
The solution that was filtered through the filter paper was collected, and the releases of Ca2+, Sr2+,
Na+, P+5, and Zn2+ in solution were quantified at different time points by using inductively coupled
plasma optical emission spectroscopy (ICP-OES; Visita Pro, Varian, Inc., Oxford, UK). Calibration
standards for ICP-OES analysis were prepared by using a Tris/HCl buffer solution in order to have a
comparable ionic strength of calibration and sample solutions. The samples were prepared by diluting
(1:5) in deionized water and adding 2% nitric acid to prevent precipitation throughout the ICP-OES test.
Scanning electron microscopy (SEM; JSM-840A, JEOL, Tokyo, Japan) was conducted on 5 mm size
samples, mounted on the aluminium stub platform, and coated with gold. SEM images were analysed
to determine the distribution of pores and to calculate the average pore size by using the ‘thickness’
algorithm in the ‘Bone J’ plugin for Image J [12].
Mechanical tests were carried out on scaffolds under compression mode by using an Instron
MTS Bionix 100 machine. The length and diameter of the samples were measured with a digital
micrometer. Tests were conducted at a crosshead speed of 2 mm/min and a load cell of 500 N by using
the ‘TestWorks 4’ software. The material stiffness (Young’s modulus E) was determined from the
stress-strain curve [12].
The Nuclear magnetic resonance (NMR) technique was performed to see the changes in the carbon
and phosphate nuclei. The NMR experiments were performed on the 600 MHz Bruker spectrometer
with the 14.1 Tesla magnetic field. The 31P MAS-NMR measurements were done at the 242.9 MHz
resonance frequency of P-31 nuclei in this field by using a 4 mm sampler holder and a rotor. The 31P
NMR experiments were done with a 60 s recycle delay. The spinning speed was about 9–10 kHz. The
85% solution of H3PO4 was used for referencing the chemical shift [25]. The 13C cross-polarization
(CP) MAS-NMR was run at the 150.9 MHz of the resonance frequency by using the 2.5 mm zirconia
rotors, which were spinning at 21 kHz with a 2 s recycle delay. The compound TMS (tetramethylsilane)
was used to reference the chemical shift scale; the signal from this solution was adjusted to 0 ppm.
2.1.2. Statistical Analysis
All pore sizes are expressed as mean ± standard deviation. Differences in collapse stress and
Young’s modulus of the glass-reinforced and pure alginate scaffolds were assessed by using the
Student’s t-test, where a p-value of less than 0.05 was considered significant.
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3. Results and Discussion
3.1. Characterization of Bioactive Glass
3.1.1. Particle Size Analysis
The size of the particle of the bioactive glasses was measured and shown in Table 3.The particles
smaller than 38 µm were used in the fabrication of scaffolds because smaller particles provide a greater
surface area of bioactive glass, providing more sites for osteoblast adhesion and osseous formation [26].
Table 3. Particle size analysis of the glass.




D(v,0.9) (90%) 13.74 65.75
D(v,0.1) (10%) 1.21 1.51
D(v0.5) (50%) 4.20 22.06
3.1.2. X-Ray Diffraction Analysis (XRD)
The XRD pattern of the A0 and A1 glasses are shown in Figure 1. A1 did not have any crystallization
peaks (Figure 1) and was therefore completely amorphous, which was exactly desirable. However,
the A0 glass had a small peak in the graph. Amorphous glasses can produce a bioactive layer. On the
other hand, crystallization reduces the bioactivity of glass [27]. A crystalline structure is responsible
for a closed glass network and makes glass solid, less soluble, and less reactive. Therefore, A0 glass
was not further characterized or used for the fabrication of scaffolds.
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3.1.3. DSC Analysis of Glass Powder
The DSC results showed that the glass transition temperature (Tg) of the A1 glass fine particles was
521 ◦C, and the first (Tc1) an second (Tc2) crystallization eaks were at 616 and 648 ◦C, respectively
(Figure 2).
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Figure 2. Differential scanning calori etry (DSC) analysis of the A1 Glass.
3.1.4. Fourier Transform Infrared (FTIR) Spectroscopy Analysis
Bioactive glasses and scaffolds were also structurally characterized by FTIR to determine their
chemical composition and to verify the presence of active Si–O groups in the glasses, as these groups
impact the glasses’ bioactivity. Data obtained from FTIR of the glass particle showed peaks at the
levels of 560, 910, and 1032 cm−1 (Figure 3).
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o e scaffolds were characterized with FTIR to ensure cross-linki g after immersion in CaCl2 and
SrCl2 soluti ns. FTIR analysis of the bone scaffolds showed the characteristic peaks of –Si–O, – H,
–COOH, and –CH. In the cross-linked samples, there was a slight s ift to the right in almost all the
absorbance peaks. In the type 1 bone scaffold (with no bioactive glass), the –COOH bond was seen at
the level of 1602 cm−1 (Figure 4a). In scaffolds that were cross-linked with calcium chloride a shift to
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the right at 1594 cm−1, as well as in the scaffold that was cross-linked with strontium, a shift to the right
at 1591 cm−1 was observed (Figure 4a). Other peaks also showed a slight shift towards the right side.
The FTIR spectrum of the type 2 scaffold (with an equal quantity of bioactive glass and alginate) that
was cross-linked with calcium chloride showed a shift of –COOH from 1599 to 1591 cm−1 (Figure 4b).
The type 3 scaffold (with twice the amount of alginate) that was cross-linked with calcium chloride
showed peaks at 1595 cm−1 and 1602 cm−1 (Figure 4c). Similar changes were observed in the FTIR
spectrum for the scaffolds that were cross-linked with calcium and strontium.
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in (a) type 1 (T1) bone scaffold (alginate only), (b) type 2 (T2) bone scaffold (alginate: bioactive glass:
1:1), and (c) type 3 (T3) bone scaffold (alginate: bioactive glass: 2:1).
The FTIR pattern shown in Figure 4 supports the results of previous studies [26,34], demonstrating
that the scaffolds that were submerged in a crosslinking solution for 3 h underwent a remarkable
physicochemical change in the scaffold, which confirmed the crosslinking of the alginate polymer
chains [26,34,35]. The cross-linking occurred at the poly G, poly M, and alternating GM regions [35].
Thus, the calcium and strontium were cross-linked in the poly G, M or alternative GM regions of
the alginate in the bone scaffold. As discussed in an earlier study [26], there is a slight shift in the
absorbance peaks of the FTIR spectrum in a cross-linked sample. This shift occurs due to the shift of the
carboxyl group. Cross-linked cations, such as calcium and strontium, interact with the –COO− group of
guluronic acid and mannuronic acid residue for the formation of the cross-links [35]. This cross-linking
makes the scaffold insoluble in an aqueous solution [7,8,36]. Cross-linking turns the scaffold into stable
hydrogels, which makes cross-linked scaffolds favourable for use as a bone material [35,36].
3.2.2. Scanning Electron Microscopy Imaging of Scaffolds
The SEM images demonstrated the porous structure of all three types of scaffolds (Figure 5).
Pores were interconnected and distributed within the body of the scaffolds. The average pore size for
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all three types of scaffolds ranged between 100 and 133 µm (see Table 4), which is adequate for the
neovascularization and nutrient/metabolic waste diffusion required for new bone formation [37–39].
The feasible pore sizes for new bone tissue growth by tissue engineering are in the range of 100–900 µm.
Outside of this range, pore sizes are too small for adequate transport over time and inhibit cell migration
and neovascularization, while larger pores reduce the surface-to-volume ratios and result in slow neo
tissue formation [40].
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scaffolds. Scaffold.
Table 4. Pore size of the scaffold expressed as mean ± S.D.
Sampl Type Pore Size (µm)
(T1) Scaffold (only alginate) 133 ± 10.5
(T2) Scaffold (alginate and bioactive glass 1:1) 100 ± 8.5
(T3) Scaffold (alginate and bioactive glass 2:1) 107 ± 8.1
A porous structure was obtained by using the sodium lauryl sulfate as a foaming agent. Pore size
was determined by using SEM and was measured with the Image J technique, but the pore size may
have been affected by the binarization of the image. More accurate techniques like mercury intrusion
and micro CT images can give more accurate data regarding pore size.
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3.2.3. Nuclear Magnetic Resonance (NMR)
Figure 6a shows the 31P MAS-NMR spectra for the selected composite scaffold samples in
comparison with the initial glass powder, before and after immersion into the Tris/HCl buffer solution.
All the spectra showed one broad unresolved signal that corresponded to an amorphous orthophosphate,
with the position varied slightly from sample to sample [41]. The peak positions extracted from the
spectra are presented in Table 5. We can see that there were no changes in the spectra of the cross-linked
scaffold compare to the initial glass powder, which implies that no changes occurred in the environment
of the phosphorus atoms in the composite scaffold compared to the glass. The peak position of the
signal clearly changed after immersion into the Tris/HCl buffer and became less positive. This could
have been due to a partial dissolution of glass during the immersion. The changes were most probably
due to Na+ and K+ ions being released from the glass and the replacement of those cations with the
available Ca2+ and Sr2+ to balance the charge of the orthophosphate. Most of the changes occurred
after the first few hours (15 h), and no changes were observed for much longer durations (two weeks).
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Figure 6b displays the 13C CP-MAS-NMR spectra of two types of scaffold samples that were
immersed for various durations, and these are compared with the initial sodium alginate powder. All
the spectra consist of three regions, according to the literature [42]. The signals denoted A, B and the
C–H group of signals. The peak positions identified from the spectra with the assignment are given in
Table 6. The region/signal between 170 and 180 ppm ‘A’ belonged to the carboxylic carbon atoms. The
region/signal between 90 nd 110 ppm ‘B’ corresponded to the anomeric region (Figure 6). M ltiple
signals from 90 to 60 ppm were assigned to the pyranose r gion, and the corresponding assignments
are plotted in Tabl 6. After cross-linking in a CaCl2 solution, a signal was observed at about 33 ppm,
which could have been assigned to an alkyl chain, cross-lin ed scaffold before and after immersion into
the Tris/HCl buffer. In addition, there was some intensity at about 61 ppm (signal H), especially clear
on the spectrum of the sample immersed for two weeks. The accurate assignment of this particular
signal has to be further clarified. A slight shift between the peak position in the cross-linked scaffold
compared to the non-cross-linked sodium alginate was also observed previously [12,23,42].
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Table 5. Assignments of the resonances in the 31P MAS-NMR spectrum (ppm).
Sample Name 31PChemical Shift at A Region (ppm)
(a) Bio glass 6.6
(b) Type 2 before cross linking 6.5
(c) Type 2 after cross linking with SrCl2 6.0
(d) Glass after 15 hrs in Tris/HCl 4.7
(e) Type 2 Srcl2 after 15 hrs in Tris/HCl 3.8
(f) Type 2 CaCl2 after 15 hrs in Tris/HCl 3.9
(g) Type 2 CaCl2 after 14 days in Tris/HCl 3.8
Table 6. Assignments of the resonances in the 13C CP-MAS-NMR spectrum (ppm).
Sample Name 13C Chemical Shift at Region (ppm)
A B C D E F G H I
(a) Sodium alginate 178 102.98 84 78 71
(b) Type 1after cross linking with SrCl2 175.8 101.3 81 76 71.8 33
(c) Type 3 after cross linking with Cacl2 176.7 102 83 76.3 71.8 33.2
(d) Type 3 cross-linked with SrCl2 after 15 hrs in Tris 177.7 103.7 82 77 73.4
(e) Type 3 cross-linked with SrCl2 after 14 days in Tris 176.8 101. 8 81.9 76.3 72 68.6 66.2 61.7
The 31P MAS-NMR (Figure 6a) showed that phosphorus existed as an orthophosphate in the
bioactive glass and should favour glass bioactivity. The solid-state NMR result also gave evidence
for slight changes in the scaffold after the cross-linking. The phosphorus environment showed small
changes. More changes were observed in the carbon spectrum (Figure 6b), including the peak positions,
which were similar to an earlier study [42].
3.2.4. Compression Testing of Scaffolds
The average Young’s modulus was calculated from the stress-strain curves obtained from all the
samples. The bone scaffold that was made with more alginate and bioactive glass (type 3 scaffolds)
demonstrated better mechanical properties in compression as compared to other scaffolds. This change
was statistically significant at p < 0.001 and p < 0.05 when comparing type 1 (pure alginate scaffolds)
with type 3 scaffolds cross-linked with CaCl2 and SrCl2, respectively (Figure 7). The average Young
modulus values calculated for type 3 scaffolds that were cross-linked with CaCl2 and SrCl2, respectively,
were 2.8 ± 1.5 and 2.74 ± 0.9 MPa as compared to 1.68 ± 0.4 and 1.8 ± 1.3 Mpa for type 2 bone scaffolds
with equal quantity of glass and alginate ration. The cross-linking agent had no overall statistically
significant effect on the material stiffness in compression. Half of the samples obtained from the type
1 scaffolds that contained the only alginate could not withstand the compression test and were crushed
immediately. The limited data obtained for type 1 scaffolds showed an average Young’s modulus of
0.2 ± 0.2 and 0.9 ± 0.3 Mpa for samples cross-linked in CaCl2 and SrCl2, respectively.
The mechanical testing results of the type 1 scaffold, which was made only with alginate, matched
with the results of a previous study [43]. The incorporation of the bioactive glass with the alginate
improved the compressive strength of the scaffold. In this project, the bioactive glass that was used
had a higher amount of strontium as compared to our earlier study [12], and cross-linking with
the strontium was done to improve the compressive strength; we were able to improve the glass’s
mechanical properties, as measured by the Youngs modulus of the composite bone scaffolds from
1.83–0.66 MPa, the value reported in our earlier study, to 2.8 ± 1.5 MPa. However, this value can be
further improved to match bone mechanical properties. Moreover, more experiments can be carried
out by using various types of alginates with varying compositions of M- and G-blocks that will affect
the mechanical properties of the alginates and the scaffolds [44].
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3.3. Tris-Buffer Study
3.3.1. pH Measurements
The pH was easured for the bone scaffold after immersion in the Tris-buffer at different time
points (Figure 8). The changes in pH were observed in the range of 7.13–7.4 for the type 1 pure alginate
scaffolds and 7.62–7.76 for the composite scaffolds. The composite scaffolds showed a slight increase in
the pH level at first, followed by a dip, and then it maintains the alkaline pH above 7.7.
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Figure 8. The changes in the pH after the immersion of T1 (pure alginate), T2 (alginate and bioactive
glass 1:1), and T3 (alginate and bioactive glass 2:1) scaffolds in the Tris-buffer solution cross-linked with
(a) calcium chloride and (b) strontium chloride.
A study of pH changes of the scaffold upon immersion into the buffer solution was performed
because it was a fast and simple test regarding how the bioactive glass or composite based on bioactive
glass would behave in vitro and in vivo [41]. The initial increase observed in the pH of the scaffolds
with bioactive glass was due to the release of ions from the bioactive glass. During the healing phase,
the normal serum pH decreased, presumably due to the accumulation of the acidic metabolites in
tissue fluids. Subsequently, the alkaline pH favoured the deposition of the mineral content. The pH
plays a regulatory role in the healing and mineralization of defect areas [45].
The pH analysis of the bone scaffold after immersion in the Tris-buffer showed a neutral to slightly
alkaline pH. The scaffold with only the alginate showed a slight decrease in the pH, whereas the
scaffold with alginate and bioactive glass in the same ratio and the scaffold with alginate and bioactive
glass with a ratio of 2:1 showed pH values in the range of the alkalinity. The alkaline pH allowed the
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bone-forming cell to form a new bone matrix. The increase in the pH in the early period was due to the
exchange of the Na+/H+ ions. The Na+ or Ca2+ near the surface of the glass went into the solution,
resulting in a pH rise. This evidence is supported by the release profile of the sodium ion, as they
showed initial increased release rates from the scaffold. The initial changes were then maintained for
the next two weeks. The bone scaffold with alginate and bioactive glass could maintain the alkaline
media that are required for the growth of a new bone matrix [45].
3.3.2. Degradation Study Using Inductive Coupled Plasma-Optical Emission Spectrometry (ICP-OES)
The release of ions from the scaffold after immersion in the Tris-buffer was quantified by the
ICP-OES, and the release profile for calcium, phosphorus, sodium, zinc, and strontium ions are shown
in Figure 9. The scaffolds were able to release ions, and the maximum release of ions was shown by the
composite scaffolds.
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The release of calcium from the T2 and T3 composite scaffolds that were cross-linked with calcium
chloride was highest. This indicates that the amount of Ca2+ release was dependent on the composition
of bioactive glass and the cross-linking agent. The trend of release seemed to be stabilized after about
one week and was maintained even after two weeks. A similar trend was observed for phosphorus,
zinc and strontium ions, with the maximum release shown by the type 3 composite scaffolds that were
linked with strontium chloride. The release of silicon ions at about 15 h was highest for the type 3
scaffolds, but at the end of two weeks, the level of the released silicon from the different scaffolds was
almost at the same point.
The release of these ions from bioactive glasses has stimulating effects on osteoblasts, regulating the
expression of several genes such as key osteoblastic markers and extracellular matrix proteins [16–18].
A recent study demonstrated that silicon-containing biomaterials are also excellent at promoting
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angiogenic events, such as endothelial (progenitor) cell homing, cell polarization, migration, angiogenic
differentiation, and neo-blood vessel sprouting [46].
3.4. Characterization of Scaffolds after Immersion in Tris-Buffer
3.4.1. Fourier Transform Infrared Spectroscopy Analysis
FTIR was performed on all three types of scaffolds after they were removed from the Tris-buffer
to evaluate the apatite formation. No change was observed in the samples that were cross-linked
with strontium chloride or calcium chloride. The FTIR spectra from type 1 and 2 samples that were
cross-linked with calcium chloride and the type 3 samples that were cross-linked with strontium
chloride are shown in Figure 10. The change in the type 1 scaffold after immersion in the Tris-buffer
was not much, and changes tended to occur within the first 15 h and then maintained that change up
to two weeks for all the scaffolds.
Bioengineering 2020, 7, x FOR PEER REVIEW 13 of 17 
3.4. Characterization of Scaffolds after Immersion in Tris-Buffer 
3.4.1. Fourier Transform Infrared Spectroscopy Analysis 
FTIR was performed on all three types of scaffolds after they were removed from the Tris-buffer 
to evaluate the apatite formation. No change was observed in the samples that were cross-linked with 
strontium chloride or calcium chloride. The FTIR spectra from type 1 and 2 samples that were cross-
linked with calcium chloride and the type 3 samples that were cross-linked with strontium chloride 
are shown in Figure 10. The change in the type 1 scaffold after immersion in the Tris-buffer was not 
much, and changes tended t  occur within the first 15 h and then maintained that change up to two 
weeks for all the scaffolds. 
Recent reports about strontium-containing bioactive glasses also showed that bands at 560 cm−1 
and 610 cm−1 and 1032 cm−1 are charact ristic of apatite formation [24]. In this study, the noise level 
at this area was more in the spectrum, and well-defined peaks were not evident in this range of the 
spectrum for any of the scaffolds and are therefore not shown in Figure 10. The absence of 
characteristic split bands at 560 and 600 cm−1 may have been a result of a mixed Ca/Sr- hydroxy-
carbonate apatite being formed, and the disordered structure of such apatite may have led to the 
broadening of the phosphate vibrational mode and the loss of this characteristic peaks. 
The non-bridging oxygen Si–O− band at 910–920 cm−1 disappeared upon immersion into the Tris-
buffer. New bands appeared at about 790 cm-1, and we assigned this to the Si–O–Si bond vibration 
between two adjacent SiO4 tetrahedra. These changes indicated the formation of a silica-gel surface 
layer after the leaching of Ca2+and Na+ and the formation of Si–OH bonds.  
 
Figure 10. FTIR spectra of type 1 (a), type 2 (b), and type 3 (c) bone scaffolds that were cross-linked 
with calcium chloride (a,b) and strontium chloride (c) after immersion in the Tris/HCl buffer at 
different time points. 
Figure 10. FTIR spectra of type 1 (a), type 2 (b), and type 3 (c) bone scaffolds that were cross-linked
with calcium chloride (a,b) and strontium chloride (c) after immersion in the Tris/HCl buffer at different
time points.
Recent reports about strontium-containing bioactive glasses also showed that bands at 560 cm−1
and 610 cm−1 and 1032 cm−1 are characteristic of apatite formation [24]. In this study, the noise level
at this area was more in the spectrum, and well-defined peaks were not evident in this range of the
spectrum for any of the scaffolds and are therefore not shown in Figure 10. The absence of characteristic
split bands at 560 and 600 cm−1 may have been a result of a mixed Ca/Sr- hydroxy-carbonate apatite
being formed, and the disordered structure of such apatite may have led to the broadening of the
phosphate vibrational mode and the loss of this characteristic peaks.
The non-bridging oxygen Si–O− band at 910–920 cm−1 disappeared upon immersion into the
Tris-buffer. New bands appeared at about 790 cm−1, and we assigned this to the Si–O–Si bond vibration
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between two adjacent SiO4 tetrahedra. These changes indicated the formation of a silica-gel surface
layer after the leaching of Ca2+and Na+ and the formation of Si–OH bonds.
All the spectra (Figure 10) clearly showed the sharpening of a band at about 1110–1030 cm−1
that is associated with both Si–O–Si and crystalline orthophosphate [40]. The band at 1020 cm−1 was
assigned to HPO42− in the crystalline apatite, and the band at 1110 cm−1 was assigned to ν1 CO32− at
the substitution site A [47].
The FTIR spectrum (Figure 10) of all the scaffolds showed the carbonate absorption bands at
1580–1600 cm−1. Peaks were more prominent in the composite scaffolds, indicating that carbonate
anions had been substituted for certain phosphate positions in the apatite lattice (B-type substitution).
In precipitated biological apatite, the predominant substitution appears to be CO32− anions for PO43−
anions, but, usually, PO43− can replace small amounts of OH− ions (A-type substitution) [47].
3.4.2. Scanning Electron Microscopy
The SEM results (Figure 11) suggested some kind of precipitation on the surface of the
scaffold. Along with other experimental data, it can be said that this precipitation was the resultant
orthophosphate, which formed as a result of the release of ions from the bone scaffold. Typical
needle-shaped hydroxyapatite crystals were not found on the surface of the scaffolds.
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3.4.3. Nuclear Magnetic Resonance (NMR) of Scaffolds after Immersion in Tris-Buffer
The NMR result (Figure 6a) also showed the unresolved signal for the calcium orthophosphate
Ca8(PO4)6H25H2O (OCP) [48].
An earlier study showed [49] that immersion of the scaffolds based on glass ceramics in a
Tris-buffer solution promoted faster degradation. Bioactive glasses with a high phosphate content after
immersion in a Tris-buffer favour the formation of an octacalcium phosphate (OCP) precursor phase
that subsequently transforms into apatite [50–52]. However, while designing bioactive glasses, it is
important to consider that, above a certain concentration of Sr or Sr/Ca ratio, the octacalcium phosphate
precursor phase is unable to form, ultimately retarding the formation of a hydroxycarbonate-like phase.
Bioengineering 2020, 7, 10 15 of 17
Moreover, the formation of OCP is generally favoured by less basic pHs, as reported in this study, and
higher P:Ca ratios [53]. A high pH > 9 promotes the direct formation of hydroxyapatite.
Further studies are underway in our laboratory to synthesize scaffolds with improved bioactivity
by using bioactive glasses with varying amounts of the concentration of strontium and phosphorus
with alginates.
4. Conclusions
A porous scaffold that was created by using strontium- and zinc-containing bioactive glass in
combination with alginate was successfully synthesized. Upon immersion in a Tris/HCl buffer solution,
the scaffolds were able to release strontium and zinc ions, and an orthophosphate layer was formed on
the surface of the scaffold; this was supported by FTIR, NMR, and ICP-OES results. The addition of
strontium in the bioactive glass enhanced the mechanical properties of the scaffolds but needs to be
further improved to match bone properties. A cell culture study followed by cytotoxic and osteogenic
differentiation assays is required before the in vivo implantation of these scaffolds.
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